Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Consolidated Net Income: 2019-2025

Historic Consolidated Net Income for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to -$9.1 million.

  • Biodesix's Consolidated Net Income rose 14.17% to -$9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.0 million, marking a year-over-year increase of 8.24%. This contributed to the annual value of -$42.8 million for FY2024, which is 15.96% up from last year.
  • Biodesix's Consolidated Net Income amounted to -$9.1 million in Q3 2025, which was up 21.45% from -$11.6 million recorded in Q2 2025.
  • Biodesix's 5-year Consolidated Net Income high stood at -$6.2 million for Q1 2021, and its period low was -$18.8 million during Q1 2023.
  • Its 3-year average for Consolidated Net Income is -$11.4 million, with a median of -$10.6 million in 2024.
  • Per our database at Business Quant, Biodesix's Consolidated Net Income slumped by 292.35% in 2021 and then surged by 44.05% in 2023.
  • Quarterly analysis of 5 years shows Biodesix's Consolidated Net Income stood at -$13.2 million in 2021, then fell by 24.78% to -$16.4 million in 2022, then skyrocketed by 44.05% to -$9.2 million in 2023, then increased by 8.67% to -$8.4 million in 2024, then climbed by 14.17% to -$9.1 million in 2025.
  • Its last three reported values are -$9.1 million in Q3 2025, -$11.6 million for Q2 2025, and -$10.8 million during Q1 2025.